These results indicate that hsa_circ_0067934 may work as an emerging potential tumor marker and therapeutic target of ESCC and cir-ITCH can inhibit the evolution of ESCC by regulating the Wnt pathway. Here, ITCH is linked to esophageal squamous cell carcinoma.